Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 194

1.

Plasma exchange treatment improves prognosis of antineutrophil cytoplasmic antibody-associated crescentic glomerulonephritis: a case-control study in 26 patients from a single center.

Frascà GM, Soverini ML, Falaschini A, Tampieri E, Vangelista A, Stefoni S.

Ther Apher Dial. 2003 Dec;7(6):540-6.

PMID:
15018241
[PubMed - indexed for MEDLINE]
2.

Clinical prognostic factors of renal outcome in anti-neutrophil cytoplasmic autoantibody (ANCA)-associated glomerulonephritis in elderly patients.

Kaplan-Pavlovcic S, Cerk K, Kveder R, Lindic J, Vizjak A.

Nephrol Dial Transplant. 2003 Jul;18 Suppl 5:v5-7.

PMID:
12817057
[PubMed - indexed for MEDLINE]
Free Article
3.

Plasma exchange treatment in rapidly progressive glomerulonephritis associated with anti-neutrophil cytoplasmic autoantibodies.

Frascà GM, Zoumparidis NG, Borgnino LC, Neri L, Vangelista A, Bonomini V.

Int J Artif Organs. 1992 Mar;15(3):181-4.

PMID:
1521903
[PubMed - indexed for MEDLINE]
4.

Urine IgM excretion predicts outcome in ANCA-associated renal vasculitis.

Bakoush O, Segelmark M, Torffvit O, Ohlsson S, Tencer J.

Nephrol Dial Transplant. 2006 May;21(5):1263-9. Epub 2006 Jan 31.

PMID:
16449276
[PubMed - indexed for MEDLINE]
Free Article
5.

Clinical outcome of patients with coexistent antineutrophil cytoplasmic antibodies and antibodies against glomerular basement membrane.

Lindic J, Vizjak A, Ferluga D, Kovac D, Ales A, Kveder R, Ponikvar R, Bren A.

Ther Apher Dial. 2009 Aug;13(4):278-81. doi: 10.1111/j.1744-9987.2009.00724.x.

PMID:
19695059
[PubMed - indexed for MEDLINE]
6.

Combined treatment in Wegener's granulomatosis with crescentic glomerulonephritis--clinical course and long-term outcome.

Frascà GM, Zoumparidis NG, Borgnino LC, Neri L, Neri L, Vangelista A, Bonomini V.

Int J Artif Organs. 1993 Jan;16(1):11-9.

PMID:
8458666
[PubMed - indexed for MEDLINE]
7.

Crescentic glomerulonephritis in Wegener's granulomatosis: morphology, therapy, outcome.

Grotz W, Wanner C, Keller E, Böhler J, Peter HH, Rohrbach R, Schollmeyer P.

Clin Nephrol. 1991 Jun;35(6):243-51.

PMID:
1873937
[PubMed - indexed for MEDLINE]
8.

Determinants of renal outcome in anti-myeloperoxidase-associated necrotizing crescentic glomerulonephritis.

Franssen CF, Stegeman CA, Oost-Kort WW, Kallenberg CG, Limburg PC, Tiebosch A, De Jong PE, Tervaert JW.

J Am Soc Nephrol. 1998 Oct;9(10):1915-23.

PMID:
9773793
[PubMed - indexed for MEDLINE]
Free Article
9.

Clinical and histologic determinants of renal outcome in ANCA-associated vasculitis: A prospective analysis of 100 patients with severe renal involvement.

de Lind van Wijngaarden RA, Hauer HA, Wolterbeek R, Jayne DR, Gaskin G, Rasmussen N, Noël LH, Ferrario F, Waldherr R, Hagen EC, Bruijn JA, Bajema IM.

J Am Soc Nephrol. 2006 Aug;17(8):2264-74. Epub 2006 Jul 6.

PMID:
16825335
[PubMed - indexed for MEDLINE]
Free Article
10.

Clinical features and outcomes in children with antineutrophil cytoplasmic autoantibody-positive glomerulonephritis associated with propylthiouracil treatment.

Fujieda M, Hattori M, Kurayama H, Koitabashi Y; Members and Coworkers of the Japanese Society for Pediatric Nephrology.

J Am Soc Nephrol. 2002 Feb;13(2):437-45.

PMID:
11805173
[PubMed - indexed for MEDLINE]
Free Article
11.

ANCA-associated glomerulonephritis/systemic vasculitis in childhood: clinical features-outcome.

Siomou E, Tramma D, Bowen C, Milford DV.

Pediatr Nephrol. 2012 Oct;27(10):1911-20. doi: 10.1007/s00467-012-2198-5. Epub 2012 May 31.

PMID:
22648163
[PubMed - indexed for MEDLINE]
12.

Necrotizing and crescentic lupus nephritis with antineutrophil cytoplasmic antibody seropositivity.

Nasr SH, D'Agati VD, Park HR, Sterman PL, Goyzueta JD, Dressler RM, Hazlett SM, Pursell RN, Caputo C, Markowitz GS.

Clin J Am Soc Nephrol. 2008 May;3(3):682-90. doi: 10.2215/CJN.04391007. Epub 2008 Feb 20.

PMID:
18287252
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Immunosuppressive therapy and clinical evolution in forty-nine patients with antineutrophil cytoplasmic antibody-associated glomerulonephritis.

Kokolina E, Alexopoulos E, Dimitriadis C, Vainas A, Giamalis P, Papagianni A, Ekonomidou D, Memmos D.

Ann N Y Acad Sci. 2005 Jun;1051:597-605.

PMID:
16127000
[PubMed - indexed for MEDLINE]
14.

Evaluation of prognostic factors for myeloperoxidase anti-neutrophil cytoplasmic antibody- (MPO-ANCA) associated glomerulonephritis.

Okano K, Yumura W, Nitta K, Honda K, Uchida K, Nihei H.

Clin Nephrol. 2001 Apr;55(4):275-81.

PMID:
11334312
[PubMed - indexed for MEDLINE]
15.

Antineutrophil cytoplasmic autoantibody-associated glomerulonephritis in children.

Hattori M, Kurayama H, Koitabashi Y; Japanese Society for Pediatric Nephrology.

J Am Soc Nephrol. 2001 Jul;12(7):1493-500.

PMID:
11423578
[PubMed - indexed for MEDLINE]
Free Article
16.

Clinical outcome of patients with Wegener's granulomatosis treated with plasma exchange.

Aasarød K, Iversen BM, Hammerstrøm J, Bostad L, Jørstad S.

Blood Purif. 2002;20(2):167-73.

PMID:
11818680
[PubMed - indexed for MEDLINE]
17.

The efficacy of an individual treatment schedule in patients with vasculitis.

Deliyska B, Shurliev V.

Nephrol Dial Transplant. 2003 Jul;18 Suppl 5:v13-5.

PMID:
12817059
[PubMed - indexed for MEDLINE]
Free Article
18.

Pulmonary renal syndrome: a 4-year, single-center experience.

Gallagher H, Kwan JT, Jayne DR.

Am J Kidney Dis. 2002 Jan;39(1):42-7.

PMID:
11774100
[PubMed - indexed for MEDLINE]
19.

Age-related variations in presentation and outcome in Wegener's granulomatosis.

Vassallo M, Shepherd RJ, Iqbal P, Feehally I.

J R Coll Physicians Lond. 1997 Jul-Aug;31(4):396-400.

PMID:
9263968
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk